Biotech

Latest Articles

Cassava spends $40M over purportedly deceiving Alzheimer's update

.Cassava Sciences has actually accepted to pay $40 million to deal with an investigation in to claim...

Merck bags options on Evaxion's AI-designed injection prospects

.Merck &amp Co. has grabbed choices on two Evaxion Biotech injection candidates, paying for $3.2 tho...

Enanta's RSV antiviral crushes viral lots in difficulty research study

.Enanta Pharmaceuticals has linked its own respiratory system syncytial infection (RSV) antiviral to...

Biogen containers SAGE-324 collaboration after important shake fail

.Biogen has administered the final ceremonies to its own collaboration with Sage Rehabs on SAGE-324,...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout credit ratings

.On the same time that some Parkinson's health condition medicines are being brought into question, ...

Arch closes $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Venture Allies is ac...

Orion to utilize Aitia's 'digital identical twins' to find new cancer medicines

.Finnish biotech Orion has snooped potential in Aitia's "digital twin" tech to establish brand-new c...

Windtree's shock med rears high blood pressure in most recent stage 2 win

.While Windtree Therapies has struggled to increase the financial origins needed to have to survive,...

2 cancer cells biotechs combine, creating global impact

.OncoC4 is taking AcroImmune-- and its own in-house medical manufacturing functionalities-- under it...

Amgen reports first stage 3 win for $400M eczema drug

.Amgen has actually shared (PDF) the 1st period 3 information on its own $400 thousand eczema medici...

Biogen, UCB file stage 3 lupus succeed after stopping working earlier test

.Biogen and also UCB's bet one's bottom dollar developing in to phase 3 astride a broken research lo...

Aptadir hopes new RNA preventions may reverse complicated cancers

.Italian biotech Aptadir Therapies has actually launched with the commitment that its own pipe of pr...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has satisfied its own target in a Duchenne muscle dystrophy (DMD) research,...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, occupyi...

Achilles drops tissue treatment system, prepares for discharges after missing out on 'business feasibility' targets

.Achilles Therapies has actually destroyed its technique. The British biotech is actually stopping w...

Aligos trumpets stage 2 MASH gain, reducing liver excess fat up to 46%

.Aligos Therapeutics is declaring a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work establishing brand new antifungals has gotten a significant increase c...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Having presently gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne mu...

FDA scraps adcomm for Applied's unusual health condition medication

.After dismissing the decision date for Applied Therapeutics' metabolic ailment medication govoresta...

Novo inks $600M NanoVation deal to study hereditary medicines ex-liver

.Novo Nordisk is proceeding its own press in to genetic medicines, accepting to compensate NanoVatio...